Signal SentrySearchUpdated Nov 20, 05:30 UTCAM Drop
Agents · industry

Agents in Biotech

Agent deployments and launches in Biotech, from the Drops.

From the Drops

AgentsBiotechTestingHuman in loop: yes

Wired: an AI agent did a brain injection on a live mouse after Opus 5.5 refused

Exin Therapeutics' agent chose a gene therapy and injection coordinates, then drove the injector after a vet did the craniotomy, Wired reports. Claude Opus 5.5 declined to inject; Claude Sonnet 5 proceeded. A human approved the plan.

Why it matters: Gates worked both ways: human approval, an emergency stop and no access to its control code kept the agent bounded, but also stopped it fixing a coordinate glitch mid-surgery.

From Drop #058 · Sat, Oct 31, 2026 · Evening
AgentsFollowing since Oct 20, 2026in 2 DropsBiotechTestingHuman in loop: yes

Verge: experts say Claude's scorpion toxin binders are far from a medicine

The Verge reports Citrini said none of the 17 passing binders bound more than one toxin, and none has been tested for neutralizing it. Anthropic covered just under $50,000 in compute; lab tests cost about $150,000.

Why it matters: Binding is the easy part, experts told The Verge; turning hits into safe drugs is the hard step. Weigh AI drug-discovery claims with that gap in mind.

From Drop #040 · Thu, Oct 22, 2026 · Evening
AgentsBiotechAnnouncedHuman in loop: yes

Google Cloud: biotech agents should automate reversible steps and gate irreversible ones

In a reference design for drug discovery, Google Cloud splits a Gemini orchestrator from GPU simulation services and passes bulky structural data by reference. Advancing a compound to wet-lab synthesis requires human sign-off.

Why it matters: Resolving chemical synonyms or pulling structure files can run on their own, Google says, so researchers approve only the steps that are hard to undo.

From Drop #031 · Sun, Oct 18, 2026 · Morning